The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib study of oral Chk1 inhibitor LY2880070 as monotherapy in patients with advanced or metastatic cancer.
 
Wilson H. Miller
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Mylan; Novartis; Roche
Research Funding - Bristol-Myers Squibb; Esperas Pharma; GlaxoSmithKline; Incyte; MedImmune; Merck; Novartis; Pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - Pfizer
 
Quincy S. Chu
Honoraria - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Lilly; Merck; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Lilly; Merck; Novartis; Pfizer; Roche; Takeda
Research Funding - AstraZeneca; Boehringer Ingelheim
 
Nathaniel Bouganim
Consulting or Advisory Role - Lilly; Merck; Novartis; Pfizer; Roche
 
Derek J. Jonker
No Relationships to Disclose
 
Gerald Batist
No Relationships to Disclose
 
Najwa J Buhlaiga
No Relationships to Disclose
 
Stephanie Lheureux
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Merck; Roche/Genentech
Research Funding - AstraZeneca (Inst); Merck (Inst); Regeneron (Inst); Roche/Genentech (Inst); Tesaro (Inst)
 
Jennifer L. Spratlin
Honoraria - Celgene; Eisai; Lilly/ImClone; Sanofi; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; Celgene; Eisai; Lilly/ImClone; Sanofi; Taiho Pharmaceutical
Research Funding - Celgene (Inst); Sanofi
Travel, Accommodations, Expenses - Astellas Pharma
 
Thierry Alcindor
Consulting or Advisory Role - Amgen; Eisai; Lilly; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer/EMD Serono; Roche Canada; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); Deciphera (Inst); EMD Serono (Inst); Epizyme (Inst); Karyopharm Therapeutics (Inst); SpringWorks Therapeutics (Inst)
 
Patricia S Smith
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Joel Owen
Employment - Cognigen Corporation
Stock and Other Ownership Interests - Simulations Plus
 
Sara L. Zaknoen
No Relationships to Disclose
 
John R. Stille
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Caroline Fortier
Employment - Esperas Pharma; PRCL Research
Leadership - AurKa Pharma; Esperas Pharma; GLWL Research; Kaneq Bioscience; Ocellaris Pharma; PRCL Research
Stock and Other Ownership Interests - BFT Cancer; InflammatoRx
Consulting or Advisory Role - AurKa Pharma; Esperas Pharma; GLWL Research; Kaneq Bioscience; Ocellaris Pharma; PRCL Research
Travel, Accommodations, Expenses - AurKa Pharma; Esperas Pharma; Ocellaris Pharma
 
Darcy Vincett
Employment - Stericycle (I)
Stock and Other Ownership Interests - Stericycle (I)
 
Amit M. Oza
Honoraria - Intas
Consulting or Advisory Role - Immunogen; Merck KGaA
Research Funding - AstraZeneca (Inst); Immunovaccine (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - AstraZeneca; Clovis Oncology; Clovis Oncology; Merck; Tesaro